The role of HLA and its coreceptors in endothelial cell activation and leukocyte recruitment in antibody-mediated transplant rejection
HLA 及其辅助受体在抗体介导的移植排斥中内皮细胞激活和白细胞募集中的作用
基本信息
- 批准号:10462514
- 负责人:
- 金额:$ 62.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2024-03-11
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdherenceAllograftingAntibodiesBindingBlood VesselsCardiacCell Culture TechniquesCell SurvivalCellsCessation of lifeChronicClinicalComplement ActivationComplexDataDepositionDevelopmentDialysis procedureDiffuseDiseaseDissectionEndothelial CellsEndotheliumEtiologyExhibitsExocytosisFibrosisFunctional disorderGraft RejectionHeart TransplantationHistocompatibility Antigens Class IIHumanITGB4 geneImmunoglobulin GIn VitroInflammationInflammatoryInjuryIntegrin beta4IntegrinsInvestigationKnowledgeLesionLeukocytesLymphocyteMediatingModelingMolecularMusOrganOrgan TransplantationOutcomeP-SelectinPathogenesisPatientsPhenotypeProcessProductionProliferatingResearchRoleSignal PathwaySignal TransductionSignaling MoleculeSmooth Muscle MyocytesTLR4 geneTestingTimeToll-like receptorsTransplantationTumor-infiltrating immune cellsVascular DiseasesVasculitisallograft rejectionantibody-mediated rejectioncell injurycombatcrosslinkfibrogenesisgraft failureheart allograftin vivomacrophagemigrationmonocytemouse modelneointima formationnovelpolarized cellprogramsreceptorrecruittherapeutic targettherapy developmenttransplant modeltreatment strategy
项目摘要
ABSTRACT
The production of donor specific HLA class I and class II antibodies is associated with development of chronic
antibody-mediated rejection (cAMR) and transplant vasculopathy (TV). Two key features of cAMR are
endothelial cell (EC) dysfunction and infiltration of immune cells, particularly macrophages. The proposed
research will explore the novel paradigm that antibody crosslinking of HLA class I with ITGB4 and TLR4 and
HLA class II with ITGB1 orchestrate divergent intracellular signaling programs in allograft endothelium inducing
functions that promote monocyte recruitment to the graft and macrophage polarization. We propose infiltrating
monocytes encounter local EC-derived factors and IgG-FcγR signals that prime them for differentiation. In the
graft, the proangiogenic/profibrotic macrophages drive neointimal thickening. Antagonizing EC activation
and/or monocyte recruitment may represent viable therapeutic targets to arrest cAMR and protect grafts from
TV. We will employ a primary human EC culture model, a mouse cardiac allograft model of TV and human
cardiac explants with TV to dissect the HLA I and II signaling pathways and mechanisms of monocyte
recruitment and polarization. Aim 1: Define the structural requirements for complex formation and functional
crosstalk between HLA Class I and its co-receptors ITGB4 and TLR4 in mediating endothelial cell activation,
monocyte recruitment and macrophage polarization in cardiac TV. We will: (1a) determine how HLA I Ab-
activated EC poise infiltrating monocytes to polarize to macrophages with distinct phenotypes and functions in
vitro; (1b) characterize monocyte recruitment, TV lesion formation and phenotypes of infiltrating macrophages
during MHC I antibody-mediated allograft injury and development of TV; (1c) define the structural requirements
and functional effects of molecular crosstalk between ITGB4, TLR4 and HLA I on monocyte recruitment and
macrophage polarization by Ab-activated EC in vitro; and (1d) characterize the requirement for MHC I co-
receptors TLR4 and ITGB4 in monocyte recruitment, macrophage polarization and TV lesion formation in
murine cardiac transplants. Aim 2. Define the structural requirements for complex formation and functional
crosstalk between HLA class II and its co-receptor ITGB1 in mediating endothelial cell activation, monocyte
recruitment and macrophage polarization in cardiac TV. We will: (2a) determine how HLA II Ab-activated EC
poise infiltrating monocytes to polarize to macrophages with divergent phenotypes and functions in vitro; (2b)
characterize monocyte recruitment, vascular lesion formation and phenotypes of infiltrating macrophages in a
murine cardiac transplant model of MHC II cAMR and TV; (2c) define the structural requirements and
functional effects of molecular crosstalk between ITGB1 and HLA II on monocyte recruitment and macrophage
polarization by Ab-activated EC in vitro; (2d) characterize the requirement for MHC II coreceptor ITGB1 in
monocyte recruitment, macrophage polarization and TV lesion formation in murine cardiac transplants; and
(2e) define the phenotype profile of intragraft macrophages in human cardiac transplants with TV.
抽象的
供体特异性 HLA I 类和 II 类抗体的产生与慢性病的发生有关
抗体介导的排斥反应(cAMR)和移植血管病变(TV)。 cAMR 的两个主要特征是
内皮细胞(EC)功能障碍和免疫细胞(特别是巨噬细胞)浸润。拟议的
研究将探索 HLA I 类与 ITGB4 和 TLR4 的抗体交联的新范例
HLA II 类与 ITGB1 在同种异体移植内皮诱导中协调不同的细胞内信号传导程序
促进单核细胞募集到移植物和巨噬细胞极化的功能。我们建议渗透
单核细胞遇到局部 EC 衍生因子和 IgG-FcγR 信号,为分化做好准备。在
移植物中,促血管生成/促纤维化巨噬细胞驱动新内膜增厚。拮抗 EC 激活
和/或单核细胞募集可能代表可行的治疗靶点,以阻止 cAMR 并保护移植物免受
电视。我们将采用原代人类 EC 培养模型、TV 和人类的小鼠心脏同种异体移植模型
心脏外植体与电视剖析单核细胞的 HLA I 和 II 信号通路和机制
招募和两极分化。目标 1:定义复杂形态和功能的结构要求
I 类 HLA 与其共受体 ITGB4 和 TLR4 之间的串扰介导内皮细胞激活,
心脏电视中的单核细胞募集和巨噬细胞极化。我们将: (1a) 确定 HLA I Ab-
激活 EC 平衡浸润单核细胞极化为具有不同表型和功能的巨噬细胞
体外; (1b) 表征单核细胞募集、电视损伤形成和浸润巨噬细胞的表型
MHC I 抗体介导的同种异体移植物损伤和 TV 发育过程中; (1c) 定义结构要求
ITGB4、TLR4 和 HLA I 之间的分子串扰对单核细胞募集和功能的影响
Ab 激活的 EC 体外极化巨噬细胞; (1d) 描述 MHC I 协同的要求
受体 TLR4 和 ITGB4 在单核细胞募集、巨噬细胞极化和 TV 病变形成中的作用
小鼠心脏移植。目标 2. 定义复杂形态和功能的结构要求
HLA II 类与其共同受体 ITGB1 之间的串扰介导内皮细胞活化、单核细胞
心脏电视中的募集和巨噬细胞极化。我们将: (2a) 确定 HLA II Ab 激活 EC 的方式
在体外使浸润单核细胞极化为具有不同表型和功能的巨噬细胞; (2b)
表征单核细胞募集、血管病变形成和浸润巨噬细胞的表型
MHC II cAMR和TV的小鼠心脏移植模型; (2c) 定义结构要求和
ITGB1 和 HLA II 之间的分子串扰对单核细胞募集和巨噬细胞的功能影响
Ab 激活的 EC 体外极化; (2d) 描述 MHC II 辅助受体 ITGB1 的要求
小鼠心脏移植中的单核细胞募集、巨噬细胞极化和 TV 损伤形成;和
(2e) 定义了 TV 人心脏移植物中移植物内巨噬细胞的表型特征。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELAINE F REED其他文献
ELAINE F REED的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELAINE F REED', 18)}}的其他基金
Human Immunomics & Trained Immunity in Persistent Candidemia
人类免疫组学
- 批准号:
10551710 - 财政年份:2023
- 资助金额:
$ 62.16万 - 项目类别:
Targeting YAP with statins to prevent antibody-mediated transplant rejection
用他汀类药物靶向 YAP 预防抗体介导的移植排斥
- 批准号:
10320048 - 财政年份:2020
- 资助金额:
$ 62.16万 - 项目类别:
The role of HLA and its coreceptors in endothelial cell activation and leukocyte recruitment in antibody-mediated transplant rejection
HLA 及其辅助受体在抗体介导的移植排斥中内皮细胞激活和白细胞募集中的作用
- 批准号:
10231220 - 财政年份:2018
- 资助金额:
$ 62.16万 - 项目类别:
Mapping Immune Responses to CMV in Renal Transplant Recipients - Transplant Supplement
绘制肾移植受者对 CMV 的免疫反应 - Transplant Supplement
- 批准号:
10225673 - 财政年份:2017
- 资助金额:
$ 62.16万 - 项目类别:
Mapping Immune Responses to CMV in Renal Transplant Recipients
绘制肾移植受者对 CMV 的免疫反应
- 批准号:
10000838 - 财政年份:2017
- 资助金额:
$ 62.16万 - 项目类别:
Ischemia-Reperfusion Injury in Human Liver Transplantation: Reciprocal Regulation of Innate/Adaptive Immune Responses
人肝移植中的缺血再灌注损伤:先天/适应性免疫反应的相互调节
- 批准号:
9975701 - 财政年份:2017
- 资助金额:
$ 62.16万 - 项目类别:
Mapping Immune Responses to CMV in Renal Transplant Recipients
绘制肾移植受者对 CMV 的免疫反应
- 批准号:
10225355 - 财政年份:2017
- 资助金额:
$ 62.16万 - 项目类别:
相似海外基金
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 62.16万 - 项目类别:
Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 62.16万 - 项目类别:
Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 62.16万 - 项目类别:
Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 62.16万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 62.16万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 62.16万 - 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 62.16万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 62.16万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 62.16万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 62.16万 - 项目类别:
Fellowship Programs














{{item.name}}会员




